États-Unis · Bourse & Finance · Barron's

How Eli Lilly Just Extended Its Lead in the Weight-Loss Drug Market

Publié par Barron's · États-Unis il y a 13 h

Eli Lilly doubles down on its pipeline with new data for weight-loss pill Foundayo and next-generation combo drug EloraTZP.

Lire l'article complet sur Barron's Connectez-vous pour sauvegarder

MediaNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.barrons.com)

À lire aussi

US Sanctions A7, a Russia Firm That Helps Sidestep Economic Restrictions

China warns foreign spies about crypto, Singapore dominates Asia: Asia Express

China Targets Solid-State Battery Dominance by 2030

Fortune 500 Chief People Officers say AI has killed org charts, and employees who will thrive need to ‘unlearn’

Lyft is paying $272.5M to settle lawsuit over how it classified drivers

Business Insider

NBCUniversal is cutting a few hundred global streaming tech employees